The NMS Patient Record Form is a comprehensive document designed to systematically capture and record significant details and interactions related to a patient's journey through the New Medicine Service (NMS). Introduced in September 2011 by the Information Department, its primary function is to aid healthcare professionals, particularly pharmacists, in monitoring and supporting patients who are initiating new medications for the first time. The form meticulously outlines various sections starting from the basic entry information, including the date and method of entry to NMS, followed by detailed patient information such as name, date of birth, address, gender, ethnicity, and NHS number. It places a strong emphasis on the condition or therapy area of the new medicine, listing common conditions like Asthma/COPD, Type 2 Diabetes, Antiplatelet/Anticoagulant therapy, and Hypertension as examples. Progress records, including initial and follow-up interventions, are crucial elements that allow pharmacists to mark the progress made with each patient. Another significant part of the form is dedicated to healthy living advice provided at each intervention stage, covering areas like smoking, diet and nutrition, physical activity, alcohol consumption, sexual health, and weight management. The form also addresses reasons for a patient’s non-participation, captures the issues identified during patient-pharmacist discussions, and outlines actions taken by pharmacists or recommended to patients to enhance therapy effectiveness. This document is not just a formality; it's a tool to ensure better patient outcomes and adherence to prescribed treatments, while also allowing for a personalized healthcare approach. Contact details for the Information Department are provided, indicating the support available for users of the form.
Question | Answer |
---|---|
Form Name | Nms Patient Record Form |
Form Length | 4 pages |
Fillable? | No |
Fillable fields | 0 |
Avg. time to fill out | 1 min |
Other names | nms forms, nms record form, nms form pdf, nms pdf |
NMS – Patient Record Form
A) Date of entry to NMS:
Method of entry to NMS:
a)Referred by prescriber
b)Patient identified in the pharmacy
Please tick one
|
B) |
Patient details |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Name: |
|
|
|
|
Date of Birth: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Address: |
|
|
|
|
Gender: |
Male / female |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ethnicity: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NHS Number:(where available) |
|
|
|
|
|
|
|
|
|
|
|
|
|
C) |
Registered GP practice: |
|
|
|||||
|
GP name (optional): |
|
|
|
|
|
|
||
|
|
|
|
|
|
||||
|
|
|
|
|
|
||||
|
D) |
Condition / therapy area(s) of new medicine |
Select |
E) Name(s) of new medicine(s) – please list |
|
||||
|
|
|
|
|
|
|
|
||
|
|
1) |
Asthma / COPD |
|
|
|
|
||
|
|
|
|
|
|
|
|
||
|
|
|
2) Diabetes (Type 2) |
|
|
|
|
||
|
|
|
|
|
|
|
|||
|
|
3) Antiplatelet / Anticoagulant therapy |
|
|
|
|
|||
|
|
|
|
|
|
|
|
||
|
|
4) |
Hypertension |
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
September 2011. Produced by the Information Department. Contact the Information Department Direct dial: 01727 891 800 or 0844 7364 201 Email: information@npa.co.uk Online: www.npa.co.uk
NMS – Patient Record Form
F) |
Progress record of NMS for this patient |
Initial intervention |
Follow up |
||
|
|
|
|
|
|
|
|
|
Date |
|
|
|
|
|
|
|
|
|
|
|
Method |
Please tick one |
|
|
|
Face to face in the pharmacy |
|
|
|
|
|
|
|
||
|
|
|
Telephone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
G) |
Healthy living advice |
Engagement |
Initial intervention |
||
|
provided at each stage |
(tick as appropriate) |
(tick as appropriate) |
(tick as appropriate) |
|
|
|
|
|
|
|
|
a) |
Smoking |
|
|
|
|
|
|
|
|
|
|
b) |
Diet and nutrition |
|
|
|
|
|
|
|
|
|
|
c) |
Physical activity |
|
|
|
|
|
|
|
|
|
|
d) |
Alcohol |
|
|
|
|
|
|
|
|
|
|
e) |
Sexual health |
|
|
|
|
|
|
|
|
|
|
f) |
Weight management |
|
|
|
|
|
|
|
|
|
|
|
|
|
||
H) |
Reason why patient did not participate in the |
Initial intervention |
|||
|
stages: |
|
|
|
|
|
|
|
|
||
a) |
Prescriber stopped new medicine |
|
|
||
|
|
|
|
||
b) |
Patient has withdrawn consent for information |
|
|
||
|
sharing |
|
|
|
|
|
|
|
|
||
c) |
Patient has withdrawn consent to receive the NMS |
|
|
||
|
|
|
|
||
d) |
Patient could not be contacted |
|
|
||
|
|
|
|
|
|
e) |
Other (Please specify) |
|
|
|
|
|
|
|
|
|
|
September 2011. Produced by the Information Department. Contact the Information Department Direct dial: 01727 891 800 or 0844 7364 201 Email: information@npa.co.uk Online: www.npa.co.uk
NMS – Patient Record Form
The data below must be recorded for each new medicine that the patient has been prescribed
New medicine: |
|
|
|
Date |
Date |
|
|
|
I) Maters identified during the discussion |
Initial |
|
|
intervention |
|
|
|
|
Patient reports…… |
|
|
a)using the medicine as prescribed
b)not using the medicine as prescribed
i.has not started using the medicines
ii.is not using the medicine in line with the directions of the prescriber
iii.patient reports missing a dose in the last 7 days
c)need for more information about the medicine
d)experiencing
e)negative feeling – provide further details in text box below
f)uncertainty on whether medicine is working
g)concern about remembering to take the medicine
h)other – free text
j)Record data about outcome of the discussion with the patient
a) Action taken / to be taken by pharmacist |
Initial |
Follow- up |
|
intervention |
|
Information provided: |
|
i.interactions with other medicines
ii.why am I using the medicine / what is it for
iii.how to use the medicine
iv.correct dose of the medicine
v.effects of the medicine on the body / how it works
vi.why should I take the medicine
vii.timing of the dose
viii.interpretation of side effect information
September 2011. Produced by the Information Department. Contact the Information Department Direct dial: 01727 891 800 or 0844 7364 201 Email: information@npa.co.uk Online: www.npa.co.uk
NMS – Patient Record Form
Advice provided: |
|
Initial |
|||
|
|
|
|
intervention |
|
|
|
|
|
||
ix. |
reminder strategies to support use of medicine |
|
|
||
|
|
|
|
||
x. |
change to timing of doses to support adherence |
|
|
||
|
|
|
|
||
xi. |
how to manage or minimise side effects |
|
|
||
|
|
|
|
||
xii. |
Yellow card report submitted to MHRA |
|
|
||
|
|
|
|
||
xiii. |
reminder chart / MAR chart provided |
|
|
||
|
|
|
|
||
xiv. |
Referral: patient raised issues about new medicine to |
Initial |
|||
|
be considered by prescriber - select reason(s) for |
intervention |
|
||
|
referral: |
|
|
|
|
|
|
|
|
|
|
|
1) |
drug interaction(s) |
|
|
|
|
|
|
|
|
|
|
2) |
potential side effect(s) / adverse drug reaction |
|
|
|
|
|
preventing use of medicine |
|
|
|
|
|
|
|
|
|
|
3) |
patient reports not using the medicine any more |
|
|
|
|
|
|
|
|
|
|
4) |
patient reports never having started the |
|
|
|
|
|
medicine |
|
|
|
|
|
|
|
|
|
|
5) |
patient reports difficulty using the medicine |
|
|
|
|
|
|
|
|
|
|
|
a) |
issue with device |
|
|
|
|
|
|
|
|
|
|
b) |
issue with formulation |
|
|
|
|
|
|
|
|
|
6) |
patient reports lack of efficacy |
|
|
|
|
|
|
|
|
|
|
7) |
patient reports problem with dosage regimen |
|
|
|
|
|
|
|
|
|
|
8) |
patient reports unresolved concern about the |
|
|
|
|
|
use of the medicine |
|
|
|
|
|
|
|
|
|
|
9) |
other – free text |
|
|
|
|
|
|
|
||
xv. |
Other action for pharmacist – free text |
|
|
||
|
|
|
|||
b) Action for PATIENT to take |
Initial |
||||
|
|
|
|
intervention |
|
|
|
|
|
||
i. |
Carry on using the medicine as prescribed |
|
|
||
|
|
|
|
||
ii. |
Use medicine as agreed during the initial intervention / |
|
|
||
|
|
|
|
||
|
|
|
|
||
iii. |
Yellow card report submitted to MHRA |
|
|
||
|
|
|
|
||
iv. |
Other action – free text |
|
|
||
|
|
|
|
|
|
September 2011. Produced by the Information Department. Contact the Information Department Direct dial: 01727 891 800 or 0844 7364 201 Email: information@npa.co.uk Online: www.npa.co.uk